Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Enamel hydroxyapatite is the primary inorganic constituent of human tooth enamel, providing the structural hardness necessary for mastication and protection of internal dental tissues (StatPearls, 2023). It consists of a crystalline calcium phosphate lattice that is susceptible to demineralization in acidic environments created by cariogenic oral bacteria (NIH, 2021). When fluoride is introduced, it interacts with this mineral to form fluorapatite or fluoridated hydroxyapatite through an ion-substitution mechanism where fluoride replaces hydroxyl ions (PubChem, CID 14781). Fluorapatite is more chemically stable and resistant to acid dissolution than pure hydroxyapatite, making it a central target for caries prevention and remineralization therapies (Wikipedia, 2024). However, excessive fluoride exposure during the developmental stages of enamel can lead to dental fluorosis, a condition where the mineral structure becomes porous and hypomineralized (PubMed, 2022). Therapeutic agents like sodium fluoride and silver diamine fluoride are specifically designed to modify this mineral substrate to enhance its durability and arrest decay.
Fluoride ions substitute hydroxyl groups in the hydroxyapatite crystal lattice to form fluorapatite, which has a lower solubility product and higher resistance to acid-induced demineralization (remineralization).
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Hydroxyapatite and Fluorapatite (HAP/FAP).